Mainz Biomed N.V. - Ordinary Shares (MYNZ)

Mainz Biomed N.V. is a biotechnology company focused on developing innovative molecular diagnostics and therapeutics for the early detection and treatment of various cancers

The company specializes in harnessing advanced biomarkers and genetic testing to empower healthcare providers and patients with accurate insights into disease risks and treatment options. By advancing personalized medicine and exploring novel diagnostic solutions, Mainz Biomed aims to enhance patient outcomes and improve the overall approach to cancer management.